Abstract
The effect of beta carotene on AMNU-induced carcinogenesis was studied in rats. Administration of beta carotene reliably decreased both the total incidence of tumors and the incidence of renal tumors. The results are an experimental validation of the possibility of using beta carotene to lower the risk of second primary malignancies during the treatment of cancer patients with nitrosoalkylurea drugs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.